Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- University of Pennsylvania
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Change in HbA1c by 3 months
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
In this study the investigators will compare a novel approach using daily financial incentives and a tiered sponsor network to motivate adolescents and young adults with type 1 diabetes to improve glycemic control.
Detailed Description
Participants will be given daily glucose monitoring goals of ≥4 glucose checks per day with ≥1 readings within goal range (70-180 mg/dL) and provided with iHealth wireless glucometers. Half of the study participants will be randomized to the 3-month intervention arm on Way to Health. The intervention includes daily financial incentives ($60 in an account at beginning of each month with $2 daily loss if non-adherent) and a 2-level tiered sponsor network (youth select 2 people who will be notified of non-adherence after 2 and 5 consecutive days). The primary outcome will be HbA1c at 3 months compared to baseline. Secondary outcomes will include HbA1c at 6 months and the proportion of participants adherent to daily glucose monitoring goals. Exit interviews will elicit intervention feasibility and feedback from a youth perspective.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of type 1 diabetes
- •HbA1c of 8 or greater
- •Receiving care from the Childrens Hospital of Philadelphia Diabetes Center
- •English-speaking
- •Owns a smartphone
Exclusion Criteria
- •New diagnosis of type 1 diabetes within past year
- •Unable to provide informed consent
- •Already participating in another study to improve glycemic control
- •Any medical conditions that would prevent completion of the study
Outcomes
Primary Outcomes
Change in HbA1c by 3 months
Time Frame: 3 months
Change in HbA1c from baseline to 3 months
Secondary Outcomes
- Glucose Monitoring Adherence by 6 months(6 months)
- Change in HbA1c by 6 months(6 months)
- Glucose Monitoring Adherence by 3 months(3 months)